LongeVC | Latest News & Updates - Feb 03, 2025 Release

Unnatural Products Inc., a LongeVC portfolio company, is pioneering AI-powered macrocyclic molecule design in collaboration with Merck to enhance drug discovery for complex diseases...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


LongeVC

🌎 longevc.com

LongeVC is a venture capital firm based in Lugano, Switzerland, founded in 2016. The company specializes in supporting early-stage biotech and longevity-focused founders, helping them gain industrial momentum, raise capital, and shape the future of the biotech industry. LongeVC aims to build a broad community of biotech innovators by funding companies in complementary sectors and facilitating collaboration among them.


LongeVC - Latest News and Updates

  • Unnatural Products Inc., a LongeVC portfolio company, is pioneering AI-powered macrocyclic molecule design in collaboration with Merck to enhance drug discovery for complex diseases.
  • LongeVC's investment in Unnatural Products Inc. has helped the company gain momentum and public presence.
  • LongeVC's portfolio company CatenaBio, based in Berkeley's Bakar Labs, was featured among Berkeley's top 10 startups to watch in 2025 for its innovative CysTyr™ platform and Multi-Payload Conjugates technology.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.